major glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 Drugs: 6 Things We've
Description
For HR and benefits leaders weighing employee interest with potential cost impact, ensuring the right patient gets the right drug at the right time is more critical than ever, says Mark Campbell, chief pharmacy officer at RxBenefits
1 is for values for the G-protein pathway
Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E
Am J Physiol Endocrinol Metab 296: E473E479
doi: 10.1016/s0140-6736(06)69705-5
